Skip to content
DraconiticResearch
Search Sources API
201,818 studies31 sourcesUpdated 11 min ago
Peer-reviewedCC BY 4.0Frontiers in Cell and Developmental Biology

Gut microbial immunometabolic pathways associated with cardiac arrest risk: genetic evidence and exploratory fecal microbiome profiling

  • Liuyang Xie1,2,3
  • Yuepeng Hu1,2,3
  • Keke Du1,2,3
  • Kecheng Liu1,2,3
  • Shibo Yang1,2,3
  • Yan Zhou1,2,3
  • Qiang Zhang1,2,3
  • Chao Lan1,2,3
  1. 1Department of Emergency Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
  2. 2Henan Provincial Engineering Research Center for Cardiopulmonary Cerebral Resuscitation, Zhengzhou, China
  3. 3Henan Engineering Research Center for Cardiopulmonary and Cerebral Resuscitation, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
Read full textPDFDOICite

Abstract

Background: Cardiac arrest remains difficult to predict, and upstream biological determinants are poorly defined. Gut microbiota can influence host metabolism, immunity and inflammation, but their relevance to cardiac arrest risk remains unclear.

Methods: We performed bidirectional two-sample Mendelian randomization to prioritize associations between gut microbial traits and cardiac arrest. Two-step mediation analyses were then used to assess whether circulating metabolites, immune cell phenotypes and inflammatory proteins could represent candidate intermediary pathways. An independent exploratory fecal 16S rRNA cohort of patients with cardiac arrest and healthy controls was analysed to provide descriptive post-arrest microbiome context.

Results: Mendelian randomization prioritized 14 candidate gut microbial taxa or microbial metabolic pathways associated with cardiac arrest risk. Mediation analyses identified 55 candidate mediation pathways involving 41 candidate mediators, including 10 pathways with comparatively stronger statistical support based on the joint-significance criterion and the Sobel test. Metabolite-related signals accounted for most candidate mediation pathways, with additional contributions from immune cell phenotypes and inflammatory factors. In the exploratory 16S cohort, diversity and ordination patterns did not show robust group separation, whereas descriptive compositional summaries showed partial taxonomic overlap with signals highlighted by the genetic analyses; these observations were not considered directional or causal validation.

Conclusion: These findings prioritize an immunometabolic framework linking gut microbial variation to cardiac arrest risk, with metabolic mediation representing the predominant candidate layer for follow-up study. The exploratory clinical 16S results provide descriptive post-arrest context rather than independent validation, and the genetic findings should be interpreted as candidate associations requiring larger prospective and experimental confirmation.

Related

  1. Gut microbiome features associated with PIK3CA-mutated colorectal cancer: A nationwide pan-cancer genomic and microbial profiling study (MONSTAR-SCREEN)
    Shogen Boku, Shunsuke A. Sakai, Kentaro Sawada +18
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationCrossref
  2. Gut Microbiome Compositional and Functional Signatures Associated with Chemotherapy Response in Pancreatic Ductal Adenocarcinoma: An Exploratory Cohort Study.
    Erica Pizzocaro, Matteo Soverini, Gian Luca Salvagno +7
    MetabolitesPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  3. Etiology-associated differences in the gut microbiome and metabolome in hepatocellular carcinoma: an exploratory study of alcohol-related and HBV-related cases
    Yongguang Wei, Kejian Yang, Qinchen Lu +7
    Frontiers in microbiologyPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCCrossref
  4. Gut microbial and metabolomic alterations associated with herpetic trigeminal neuralgia: an exploratory multi-omics study.
    Mingyue Tian, Yangyang Wang, Cong Li +5
    Journal of oral & facial pain and headachePeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  5. Gut microbial metabolism in aging: from metabolite production to organ-specific immunometabolic effects
    Zhen Wang, Yang Liu
    Frontiers in nutritionPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMCEurope PMCPMC

Cite

BibTeXRIS
BibTeX
@article{xie2026microbial,
  title = {{Gut microbial immunometabolic pathways associated with cardiac arrest risk: genetic evidence and exploratory fecal microbiome profiling}},
  author = {Liuyang Xie and Yuepeng Hu and Keke Du and Kecheng Liu and Shibo Yang and Yan Zhou and Qiang Zhang and Chao Lan},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2026},
  month = oct,
  doi = {10.3389/fcell.2026.1931987},
  url = {https://doi.org/10.3389/fcell.2026.1931987},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Gut microbial immunometabolic pathways associated with cardiac arrest risk: genetic evidence and exploratory fecal microbiome profiling
AU  - Liuyang Xie
AU  - Yuepeng Hu
AU  - Keke Du
AU  - Kecheng Liu
AU  - Shibo Yang
AU  - Yan Zhou
AU  - Qiang Zhang
AU  - Chao Lan
PY  - 2026
DA  - 2026/10/13
JO  - Frontiers in Cell and Developmental Biology
DO  - 10.3389/fcell.2026.1931987
UR  - https://doi.org/10.3389/fcell.2026.1931987
AB  - Background: Cardiac arrest remains difficult to predict, and upstream biological determinants are poorly defined. Gut microbiota can influence host metabolism, immunity and inflammation, but their relevance to cardiac arrest risk remains unclear.  Methods: We performed bidirectional two-sample Mendelian randomization to prioritize associations between gut microbial traits and cardiac arrest. Two-step mediation analyses were then used to assess whether circulating metabolites, immune cell phenotypes and inflammatory proteins could represent candidate intermediary pathways. An independent exploratory fecal 16S rRNA cohort of patients with cardiac arrest and healthy controls was analysed to provide descriptive post-arrest microbiome context.  Results: Mendelian randomization prioritized 14 candidate gut microbial taxa or microbial metabolic pathways associated with cardiac arrest risk. Mediation analyses identified 55 candidate mediation pathways involving 41 candidate mediators, including 10 pathways with comparatively stronger statistical support based on the joint-significance criterion and the Sobel test. Metabolite-related signals accounted for most candidate mediation pathways, with additional contributions from immune cell phenotypes and inflammatory factors. In the exploratory 16S cohort, diversity and ordination patterns did not show robust group separation, whereas descriptive compositional summaries showed partial taxonomic overlap with signals highlighted by the genetic analyses; these observations were not considered directional or causal validation.  Conclusion: These findings prioritize an immunometabolic framework linking gut microbial variation to cardiac arrest risk, with metabolic mediation representing the predominant candidate layer for follow-up study. The exploratory clinical 16S results provide descriptive post-arrest context rather than independent validation, and the genetic findings should be interpreted as candidate associations requiring larger prospective and experimental confirmation.
SN  - 2296-634X
ER  -